All of these factors suggested that elevated levels of inflammation and hypoxia, along with dysregulated HIF‐1α/eNOS pathway, were involved in the pathogenesis of CTEPH. This evidence concerns the gene HIF1A and chronic thromboembolic pulmonary hypertension.